MedPath

A retrospective cohort study of Professor Liu Jing's medication rule in the treatment of adenoidal hypertrophy in childre

Phase 2
Conditions
Adenoidal Hypertrophy
Registration Number
ITMCTR2023000004
Lead Sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) The outpatient electronic medical record system ICD diagnosis is adenoid hypertrophy;
(2) Age between 3 and 10 years old;
(3) After treatment, complete medical records of initial and follow-up visits are available

Exclusion Criteria

(1) Children with poor breathing caused by obesity, nasal polyps, deflection of nasal septum and other reasons;
(2) Severe impact on sleep, combined with severe primary systemic diseases such as heart, brain, lung, liver, kidney, and hematopoiesis;
(3) Children with severe malnutrition, dysfunction, severe rickets, and mental illness;
(4) Those who received adenoidectomy during treatment

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retrospective Study of Clinical Manifestation Collection Scoring Table for Children with Adenoid Hypertrophy;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath